I've talked about the bills that got out of committee. I won't repeat that for your question. These bills will bring cheaper treatment faster to the market and hold drug companies and PBMS accountable. The Senate has now passed just one of these six competition bills. So for you, what impact would these remaining five bills have on patients and why should the Senate act now? Thank you for your question. (01:16–01:23)
STATEMENT
Asserts that the Senate has passed only one out of six competition bills aimed at reducing drug costs.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.